Douglas Earl Martin
Insider CIK 1362155 · BMTI General Counsel · ALLO SVP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics, Inc | S Sale | 2026-08-21 | 2026-08-25 | 29,697 | $2.12 | $63.0K | 488,267 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2026-08-21 | 2026-08-25 | 29,697 | $2.12 | $63.0K | 488,267 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 539,072 | — | $0 | 539,072 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 152,480 | — | $0 | 152,480 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2026-02-02 | 2026-02-04 | 22,900 | $1.76 | $40.3K | 564,948 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | S Sale | 2025-02-03 | 2025-02-05 | 6,404 | $1.71 | $11.0K | 587,848 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2025-01-24 | 2025-01-28 | 512,370 | — | $0 | 512,370 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2025-01-24 | 2025-01-28 | 144,928 | — | $0 | 594,252 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | F Tax w/h | 2024-08-21 | 2024-08-23 | 28,310 | $2.79 | $79.0K | 449,324 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2024-01-25 | 2024-01-31 | 147,778 | — | $0 | 147,778 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2024-01-25 | 2024-01-31 | 41,800 | — | $0 | 477,634 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-08-14 | 2023-08-17 | 960,854 | — | $0 | 960,854 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-08-14 | 2023-08-17 | 108,958 | — | $0 | 108,958 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-08-14 | 2023-08-17 | 326,876 | — | $0 | 435,834 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 5,000 | $2.35 | $11.8K | 53,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 1,100 | $2.32 | $2.6K | 52,417 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 200 | $2.33 | $466 | 52,217 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 3,300 | $2.34 | $7.7K | 48,917 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 1,400 | $2.33 | $3.3K | 47,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 6,000 | $2.35 | $14.1K | 41,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 3,000 | $2.34 | $7.0K | 38,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 5,000 | $2.36 | $11.8K | 33,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 1,300 | $2.35 | $3.1K | 32,217 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 400 | $2.35 | $940 | 31,817 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 300 | $2.35 | $705 | 31,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 2,000 | $2.36 | $4.7K | 29,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 5,000 | $2.37 | $11.8K | 24,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 8,000 | $2.35 | $18.8K | 11,056 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 461 | $2.37 | $1.1K | 19,056 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-28 | 2012-03-28 | 5,000 | $2.38 | $11.9K | 19,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-27 | 2012-03-28 | 5,000 | $2.34 | $11.7K | 58,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | S Sale | 2012-03-26 | 2012-03-28 | 1,100 | $2.35 | $2.6K | 63,517 | SEC↗ |
| BMTI BIOMIMETIC THERAPEUTICS, I | A Award deriv | 2012-02-29 | 2012-03-02 | 80,000 | — | $0 | 80,000 | SEC↗ |